Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Nov 11 - release its third quarter 2021 financial results

<< Previous

Bullboard Posts

Next >>

Comment by ferret_caon Nov 09, 2021 12:37pm

64 Views

Post# 34105352

RE:RE:RE:RE:RE:RE:RE:RE:Nov 11 - release its third quarter 2021 financial results

gud's disrespectful mgmt need to get their heads outta their a$$es for having their conf call on remembrance day, what a bunch of dipsheets, show some respect you bumbling a h o l e s.

<< Previous

Bullboard Posts

Next >>

Mastering options Greeks: Essential knowledge for informed trading